Pharmacogenomic of LH and its receptor: are we ready for clinical practice?
Pharmacogenomic of LH and its receptor: are we ready for clinical practice?
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Luteinizing hormone (LH) is fundamental to support development and reproduction. It acts through a receptor expressed in the gonads, modulating mitogenic, anti-apoptotic, and steroidogenic signals. LH is also marketed as a drug for controlled ovarian stimulation (COS), where it is administered to women to support the action of follicle-stimulating...
Alternative Titles
Full title
Pharmacogenomic of LH and its receptor: are we ready for clinical practice?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_168ad907252d409fa6c46ff5d9b58b8d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_168ad907252d409fa6c46ff5d9b58b8d
Other Identifiers
ISSN
1477-7827
E-ISSN
1477-7827
DOI
10.1186/s12958-025-01359-2
